| Gene symbol | tk |
| GTO ID | GTC0333 |
| Trial ID | NCT02894944 |
| Disease | Pancreatic Cancer |
| Altered gene | yCD|tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | DNA oncolytic virus |
| Treatment | Theragene |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Clinical Trial Phase I for Evaluation of Tolerability and Safety of Replication-competent Adenovirus-mediated Double Suicide Gene Therapy in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer |
| Year | 2016 |
| Country | Korea,Republic of |
| Company sponsor | Seoul National University Hospital |
| Other ID(s) | SNUBH-IMGPB-2016-02 |
| Vector information | |||
|
|||
| Cohort1: dose level 1 | |||||||||||||||
|
|||||||||||||||
| Cohort2: dose level 2 | |||||||||||||||
|
|||||||||||||||
| Cohort3: dose level 3 | |||||||||||||||
|
|||||||||||||||